<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03392025</url>
  </required_header>
  <id_info>
    <org_study_id>651</org_study_id>
    <nct_id>NCT03392025</nct_id>
  </id_info>
  <brief_title>Flaxseed Consumption, Alone and in Combination With the Mediterranean-like Diet, on Some Indicators Related to Atherosclerosis</brief_title>
  <official_title>Effects of Flaxseed Consumption, Alone and in Combination With the Mediterranean-like Diet, on Vascular Endothelial Function and Some Biochemical Indicators Related to Atherosclerosis in Patients With Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Javad Nasrollahzadeh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Flaxseed consumption has beneficial effects on cardiovascular risk factors. In addition, the
      benefit of the Mediterranean-like diet in primary and secondary prevention of cardiovascular
      diseases has been shown.The purpose of this study is to investigate the effects of flaxseed
      consumption, alone and in combination with the Mediterranean-like diet, in adjunct to
      conventional medical treatment, in improving vascular endothelial function, plasma lipid
      profile and high sensitivity c-reactive protein of coronary artery disease (CAD) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized placebo controlled clinical trial will be conducted in Rajaie Cardiovascular
      Center in Tehran, Iran. After review of the inclusion and exclusion criteria and explanation
      of the design of the study, written consent form will be completed. The participants are 81
      eligible coronary artery disease patients, aged 20-75 years. Intervention groups will be
      received 30 g/d flaxseed, alone, or with weekly Mediterranean-like diet menu and control
      group will be received capsules of wheat fiber as placebo for 3 months. Vascular endothelial
      function will be evaluated through measurement of flow mediated dilatation (FMD) in brachial
      artery and carotid intima-media thickness (c-IMT) via ultrasound sonography and plasma level
      of asymmetric di-methyl arginine (ADMA). Fasting blood sample will be taken to measure
      malondialdehyde (MDA), lipid profile, high sensitive C-reactive protein and inflammatory
      cytokines (Interleukine-6 [IL-6] and Tumor Necrosis Factor-a [TNF-a]).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">May 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow Mediated Dilatation (FMD)</measure>
    <time_frame>3 month</time_frame>
    <description>Change in dilatation of the brachial artery from baseline at 3 month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma level of high sensitive C reactive protein (hs-CRP)</measure>
    <time_frame>3 month</time_frame>
    <description>change in plasma level of high sensitive C reactive protein (hs-CRP) from baseline at 3 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma lipid profile</measure>
    <time_frame>3 month</time_frame>
    <description>change in plasma level of lipid profile from baseline at 3 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>carotid intima-media thickness (c-IMT)</measure>
    <time_frame>3 month</time_frame>
    <description>change in carotid intima-media thickness from baseline at 3 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>asymmetric di-methyl arginine (ADMA)</measure>
    <time_frame>3 month</time_frame>
    <description>change in plasma level of assymetric di-methyl arginine from baseline at 3 month</description>
  </secondary_outcome>
  <other_outcome>
    <measure>plasma levels of Interleukine-6 (IL-6)</measure>
    <time_frame>3 month</time_frame>
    <description>change in plasma levels of IL-6 from baseline at 3 month</description>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of malondialdehyde (MDA)</measure>
    <time_frame>3 month</time_frame>
    <description>change in plasma levels of MDA from baseline at 3 month</description>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of Tumor Necrosis Factor-alfa (TNF-a)</measure>
    <time_frame>3 month</time_frame>
    <description>change in plasma levels of TNF-a from baseline at 3 month</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Flaxseed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily consumption of 30 grams flaxseed for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flaxseed and the Mediterranean-like diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily consumption of 30 grams flaxseed in adjunct to the Mediterranean-like diet for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily consumption of Placebo for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flaxseed</intervention_name>
    <description>Daily consumption of 30 grams flaxseed in adjunct to medical treatment for 3 months</description>
    <arm_group_label>Flaxseed</arm_group_label>
    <arm_group_label>Flaxseed and the Mediterranean-like diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>the Mediterranean-like diet</intervention_name>
    <description>Weekly Mediterranean-like diet menu in adjunct to medical treatment for 3 months</description>
    <arm_group_label>Flaxseed and the Mediterranean-like diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily consumption of one capsule of wheat fiber as placebo in adjunct to medical treatment for 3 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. coronary artery disease patients (more than 50% blockage in coronary arteries) needed
             angioplasty with stent

          2. willing to participation in the study

        Exclusion Criteria:

          1. cigarette Smoking

          2. continuous consumption of any antioxidant supplement such as vitamin E, vitamin C and
             Selenium in last month

          3. consumption of flaxseed or any omega-3 supplement at the beginning of the study

          4. َadvanced renal disease

          5. unwillingness to continuance

          6. any change in disease treatment plan such as change in type and dose of lipid lowering
             drugs or surgical operation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javad Nasrollahzadeh, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Nutrition and Diet Therapy, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javad Nasrollahzadeh, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Department of Clinical Nutrition and Diet Therapy, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nafiseh Khandouzi, Ph.D student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Nutrition and Diet Therapy, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Javad Nasrollahzadeh, Ph.D</last_name>
    <phone>00989122446911</phone>
    <email>jnasrollahzadeh@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rajaie Cardiovascular, Medical &amp; Research Center</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Zahedmehr, MD</last_name>
      <phone>00989125133270</phone>
      <email>arashzahedmehr@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Nafiseh Khandouzi, Ph.D student</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <reference>
    <citation>Cassani RS, Fassini PG, Silvah JH, Lima CM, Marchini JS. Retraction Note: Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study. Nutr J. 2016 Jun 7;15(1):59.</citation>
    <PMID>27267967</PMID>
  </reference>
  <reference>
    <citation>Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015 Mar;128(3):229-38. doi: 10.1016/j.amjmed.2014.10.014. Epub 2014 Oct 15. Review.</citation>
    <PMID>25447615</PMID>
  </reference>
  <reference>
    <citation>Ros E, Martínez-González MA, Estruch R, Salas-Salvadó J, Fitó M, Martínez JA, Corella D. Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study. Adv Nutr. 2014 May 14;5(3):330S-6S. doi: 10.3945/an.113.005389. Print 2014 May. Review.</citation>
    <PMID>24829485</PMID>
  </reference>
  <reference>
    <citation>Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, Szapary PO. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr. 2008 Feb;27(1):65-74.</citation>
    <PMID>18460483</PMID>
  </reference>
  <reference>
    <citation>Fuentes F, López-Miranda J, Sánchez E, Sánchez F, Paez J, Paz-Rojas E, Marín C, Gómez P, Jimenez-Perepérez J, Ordovás JM, Pérez-Jiménez F. Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med. 2001 Jun 19;134(12):1115-9.</citation>
    <PMID>11412051</PMID>
  </reference>
  <reference>
    <citation>Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, Fiol M, Gómez-Gracia E, López-Sabater MC, Vinyoles E, Arós F, Conde M, Lahoz C, Lapetra J, Sáez G, Ros E; PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006 Jul 4;145(1):1-11.</citation>
    <PMID>16818923</PMID>
  </reference>
  <reference>
    <citation>Murie-Fernandez M, Irimia P, Toledo E, Martínez-Vila E, Buil-Cosiales P, Serrano-Martínez M, Ruiz-Gutiérrez V, Ros E, Estruch R, Martínez-González MÁ; PREDIMED Investigators. Carotid intima-media thickness changes with Mediterranean diet: a randomized trial (PREDIMED-Navarra). Atherosclerosis. 2011 Nov;219(1):158-62. doi: 10.1016/j.atherosclerosis.2011.06.050. Epub 2011 Jul 6.</citation>
    <PMID>21802081</PMID>
  </reference>
  <reference>
    <citation>Marin C, Ramirez R, Delgado-Lista J, Yubero-Serrano EM, Perez-Martinez P, Carracedo J, Garcia-Rios A, Rodriguez F, Gutierrez-Mariscal FM, Gomez P, Perez-Jimenez F, Lopez-Miranda J. Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium. Am J Clin Nutr. 2011 Feb;93(2):267-74. doi: 10.3945/ajcn.110.006866. Epub 2010 Dec 1.</citation>
    <PMID>21123460</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2017</study_first_submitted>
  <study_first_submitted_qc>January 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2018</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University</investigator_affiliation>
    <investigator_full_name>Javad Nasrollahzadeh</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

